Cross-platform comparison of the quality, reliability, and engagement of endometriosis-related videos on TikTok and Bilibili: A cross-sectional study

TikTok和Bilibili上子宫内膜异位症相关视频的质量、可靠性和互动性的跨平台比较:一项横断面研究

阅读:1

Abstract

OBJECTIVE: To evaluate the quality, reliability, and user engagement of endometriosis-related videos on TikTok and Bilibili, identifying variations by platform, uploader type, and content category to inform digital health strategies. METHODS: The top 100 videos per platform were retrieved using the Chinese keyword for "endometriosis." After excluding irrelevant or promotional content, 195 videos (99 TikTok, 96 Bilibili) were analyzed. Categorization included uploader type (professional individuals, nonprofessionals, institutions) and content (disease knowledge, treatment, Traditional Chinese Medicine, other). Quality was assessed via Global Quality Score (GQS), modified DISCERN (mDISCERN), JAMA benchmarks, and Video Information and Quality Index (VIQI). Engagement (likes, collections, comments, shares) and duration were recorded. Analyses used the Wilcoxon rank-sum, Kruskal-Wallis, Fisher's exact, and Spearman correlations. RESULTS: Professionals uploaded 83.6% of videos; disease knowledge dominated (64.1%). Bilibili videos were longer (median 281.5 vs. 64.67 s; P < .0001) with higher GQS (3.29 vs. 3.04; P = .0123), mDISCERN (3 vs. 2; P < .0001), and JAMA (1 vs. 0; P < .0001). TikTok excelled in engagement (e.g., likes 355 vs. 18.5; P < .0001). Professional sources scored higher (P < .001-.003). Treatment content was most engaging but shorter (P < .001). Engagement correlated internally (P > .7) but weakly with quality (P < .3). CONCLUSIONS: Videos show moderate quality, with Bilibili emphasizing reliability and TikTok virality. Professional content is superior, but the popularity-quality disconnect highlights needs for verification and education to reduce misinformation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。